{
  "pmcid": "10980176",
  "sha256": "8ebe67c5ef239450af4a81b17cae9382eb6db93fe5ceb8dad9402bc62c422f6e",
  "timestamp_utc": "2025-11-09T23:11:05.092003+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.90268343815514,
    "reading_ease": 34.3771139063592,
    "word_count": 265
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Aspirin and Low-Molecular-Weight Heparin for Thromboprophylaxis in Orthopaedic Trauma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Adult patients with operatively treated extremity fractures or pelvic/acetabular fractures were randomly assigned"
      },
      "Participants": {
        "score": 2,
        "evidence": "Adult patients with operatively treated extremity fractures or pelvic/acetabular fractures"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to receive 30 mg of low-molecular-weight heparin twice daily or 81 mg of aspirin twice daily"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare patient satisfaction and out-of-pocket costs between aspirin and low-molecular-weight heparin."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were patient satisfaction and out-of-pocket costs, measured 90 days post-randomization."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomization was 1:1, and allocation was not concealed from patients or clinicians."
      },
      "Blinding": {
        "score": 0,
        "evidence": "allocation was not concealed from patients or clinicians"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "The trial enrolled 12,211 patients from April 2017 to August 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 12,211 patients, 9725 completed the satisfaction question, and 6723 reported out-of-pocket costs."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Patients assigned to aspirin had 2.6 times higher odds of satisfaction (OR: 2.59; 95% CI: 2.39 to 2.80; p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered at ClinicalTrials.gov (NCT02984384)"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by the University of Maryland School of Medicine and METRC."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}